NZ598702A - A micro-rna family that modulates fibrosis and uses thereof - Google Patents
A micro-rna family that modulates fibrosis and uses thereofInfo
- Publication number
- NZ598702A NZ598702A NZ598702A NZ59870208A NZ598702A NZ 598702 A NZ598702 A NZ 598702A NZ 598702 A NZ598702 A NZ 598702A NZ 59870208 A NZ59870208 A NZ 59870208A NZ 598702 A NZ598702 A NZ 598702A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mir
- sequence
- antisense oligonucleotide
- micro
- medicament
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ61479108A NZ614791A (en) | 2007-07-31 | 2008-07-31 | A micro-rna family that modulates fibrosis and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95291707P | 2007-07-31 | 2007-07-31 | |
US98030307P | 2007-10-16 | 2007-10-16 | |
US4701408P | 2008-04-22 | 2008-04-22 | |
NZ583024A NZ583024A (en) | 2007-07-31 | 2008-07-31 | An agonist of miR-29a, miR-29b or miR-29c that prevents tissue fibrosis and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ598702A true NZ598702A (en) | 2014-01-31 |
Family
ID=50619560
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ598702A NZ598702A (en) | 2007-07-31 | 2008-07-31 | A micro-rna family that modulates fibrosis and uses thereof |
NZ61479108A NZ614791A (en) | 2007-07-31 | 2008-07-31 | A micro-rna family that modulates fibrosis and uses thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ61479108A NZ614791A (en) | 2007-07-31 | 2008-07-31 | A micro-rna family that modulates fibrosis and uses thereof |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN105030808B (en) |
NZ (2) | NZ598702A (en) |
PL (1) | PL2182969T3 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420405B (en) * | 2015-12-30 | 2018-12-07 | 山东农业大学 | The cow's serum microRNA molecule of milk cow Fatty Liver Disease and cow in perinatal period related metabolic diseases label |
WO2017219168A1 (en) * | 2016-06-19 | 2017-12-28 | 毛侃琅 | Lentiviral vector for knocking down mirna-29a and mir-152 expressions, and application thereof |
WO2019109026A1 (en) * | 2017-11-30 | 2019-06-06 | MiRagen Therapeutics, Inc. | miR29 MIMICS FOR THE TREATMENT OF OCULAR FIBROSIS |
CN108690846A (en) * | 2018-04-17 | 2018-10-23 | 上海大学 | Inhibit the application of MiR-29b gene expressions |
CN109762883B (en) * | 2019-01-31 | 2020-01-21 | 温州医科大学 | Application of plasma/serum exosome hsa-miRNA-29-3p as glaucoma diagnosis marker |
CN110283901A (en) * | 2019-07-25 | 2019-09-27 | 青岛大学 | MiRNA probe compositions, Primer composition and diagnosis of coronary heart disease kit for diagnosis of coronary heart disease |
CN111249466B (en) * | 2020-03-14 | 2022-04-15 | 浙江大学医学院附属第一医院 | Application of tanshinone IIA and miR-29b inhibitor in preparation of medicine for treating tendon adhesion |
CN111647656A (en) * | 2020-05-15 | 2020-09-11 | 华中科技大学同济医学院附属同济医院 | Application of mir-29a gene in detection of liver cancer and liver fibrosis and construction method of conditional knock-in mouse of gene |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007281261B2 (en) * | 2006-08-01 | 2013-03-21 | Board Of Regents Of The University Of Texas System | Identification of a micro-RNA that activates expression of beta-myosin heavy chain |
-
2008
- 2008-07-31 NZ NZ598702A patent/NZ598702A/en not_active IP Right Cessation
- 2008-07-31 CN CN201510363301.5A patent/CN105030808B/en active Active
- 2008-07-31 PL PL08797006T patent/PL2182969T3/en unknown
- 2008-07-31 NZ NZ61479108A patent/NZ614791A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN105030808B (en) | 2018-12-14 |
NZ614791A (en) | 2015-03-27 |
CN105030808A (en) | 2015-11-11 |
PL2182969T3 (en) | 2017-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ598702A (en) | A micro-rna family that modulates fibrosis and uses thereof | |
EP4327867A3 (en) | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient | |
CA3094580C (en) | Oral formulations of cytidine analogs and methods of use thereof | |
EP3210633A3 (en) | Compositions and their uses directed to huntingtin | |
MX2010014234A (en) | Pyrazole compounds 436. | |
NZ624783A (en) | Modulation of huntingtin expression | |
MY147994A (en) | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors | |
TW200635924A (en) | Chemical compounds | |
UA105644C2 (en) | Methods of treating pulmonary disorders with liposomal amikacin formulations | |
MX2011012122A (en) | Thiophene derivatives. | |
MY169564A (en) | Substituted dihydropyrazolones and their use | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
WO2007131232A3 (en) | Compositions and their uses directed to ptpr alpha | |
WO2008045559A3 (en) | Methods of treating oral mucositis | |
WO2007027477A3 (en) | Treating vulvodynia using prodrugs of gaba analogs | |
TNSN08506A1 (en) | Substituted carboxamides | |
MX2009006325A (en) | 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents. | |
TW200942529A (en) | Pyrrolidinyl derivatives and uses thereof | |
PT1638582E (en) | Use of hyaluronic acid for preparing compositions for treating recurrent oral cavity aphthas | |
WO2007036771A3 (en) | Pantoprazole free acid form iii | |
MX2008015323A (en) | Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association. | |
WO2011028799A3 (en) | Ganglioside transmucosal formulations | |
WO2007144889A3 (en) | Treatment of neurofibromatosis | |
DE502007003367D1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INCONTINENCE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 31 JUL 2015 BY PIZZEYS PATENT AND TRADE MARK ATTORNEYS Effective date: 20140507 |
|
ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 1018264, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, 201 WEST 7TH STREET, AUSTIN, TX 78701, US Effective date: 20140808 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 JUL 2016 BY CPA GLOBAL Effective date: 20150620 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 JUL 2017 BY CPA GLOBAL Effective date: 20160617 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 JUL 2018 BY CPA GLOBAL Effective date: 20170615 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 JUL 2019 BY CPA GLOBAL Effective date: 20180614 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 JUL 2020 BY CPA GLOBAL Effective date: 20190620 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 JUL 2021 BY CPA GLOBAL Effective date: 20200723 |
|
LAPS | Patent lapsed |